Saturday, June 25, 2022

Early Trauma, Social Stress Accompany Psychosis

0
Researchers at Emory University find that childhood trauma, sensitivity to psychosocial stress and a heightened biological response to stress are associated with the onset...

Discontinuing Psychotropics Reduces Falls in Elderly

0
Australian researchers look at the literature on the effect of psychotropics on falls in the elderly; largest effect of any randomized trial was achieved...

Evidence That Sadness When Bereaved is Not Illness

0
While the DSM-IV recognizes that depressive symptoms are sometimes normal in bereaved individuals, this "Bereavement Exclusion" is targeted for elimination from the DSM-V. However...

Pfizer Files to Consolidate Birth Defect Lawsuitsd

0
With at least 59 lawsuits pending over birth defects allegedly caused by Zoloft, Pfizer moves to consolidate litigation near its headquarters in New York. Read...

J&J Earnings Down 89%

0
The Wall Street Journal reports that Johnson & Johnson's fourth-quarter earnings fell 89% following settlements for misrepresenting the risks and benefits of Risperdal, its...

Alarm About Antipsychotics as Sleep Aids

0
Canadian sleep researchers, writing in The Lancet, warn that weight gain, lipid and glucose dysregulation, restless leg syndrome, sleep-walking and eating while asleep, and...

Elevated Diabetes in Children Treated With Antipsychotics, Antidepressants

0
Researchers at the University of Massachusetts found that children are more than twice as likely to develop diabetes when treated with antidepressants, and more...

J&J Takes Hit on Wall Street for Its Corrupt Practices

0
In the wake of the Johnson & Johnson's settlements over its improper marketing of Risperdal, Forbes magazine comments on the company's "vulnerable and now...

J&J Settles Texas Medicaid Lawsuit for $158 Million

0
Johnson & Johnson has agreed to settle Texas' lawsuit for the company's fraudulent marketing of Risperdal. The is the first time J&J has settled...

Bipolar Office Visits Soar

0
The number of "visits" by bipolar patients 18 and older to office-based physicians in the U.S. rose from 3.7 million in 1998 to 7.8...

One in Five Americans Uses a Psychiatric Drug

0
Because of the increased use of generic drugs, there has been a slowdown in the growth of spending for psychiatric drugs in the United...

Nicotine Replacement Therapies Fail to Provide a Lasting Benefit

0
In clinical trials, nicotine gum and patches are effective in helping people quit smoking. However, researchers have found that nicotine-replacement therapies do not lower...

Texas Lawsuit Against J&J Underway

0
Texas' lawsuit against Johnson & Johnson for its off-label marketing of Risperdal, which the state alleges involved fraudulent claims about the drug's safety and...

Why Marijuana Can Trigger Psychosis

0
Brain scans by London researchers show why marijuana calms some people, but can cause psychosis or paranoid thoughts in others. They found that THC...

J & J to Pay More Than $1 Billion For Wrongful Marketing of Risperdal

0
In order to resolve a civil investigation into the marketing of Risperdal for unapproved uses, Johnson & Johnson will pay more than $1 billion...

Why Trials of Antidepressants Often Fail 

0
In a review of seven clinical trials of duloxetine (Cymbalta), researchers found that the drug-treated patients fell into two groups: 76.7% "responded" to the...

Psychiatric Hospitalization of Children Soars

0
From 1996 to 2007, the number of children ages five to 13 discharged from a psychiatric inpatient unit nearly doubled on a per-capita basis....

Antipsychotic Drugs and the Risk of Hyperglycemia in Older Adults Without Diabetes: A Population-Based...

0
  Objective: To determine whether current antipsychotic use among older persons without diabetes is associated with a higher risk of hospital visits for hyperglycemia, as...

Polypharmacy/Bipolar illness

7
  A. Bipolar Illness Before the Psychopharmacology Era Prior to 1955, bipolar illness was a rare disorder. There were only 12,750 people  hospitalized with that disorder...

Wired Magazine on the DSM and Allen Frances

0
Article from Wired magazine in 2010 about Allen Frances, lead editor of the DSM-IV, and his criticism of both the DSM-IV and the upcoming DSM-5. Article → 

Follow Us

31,706FansLike
26,963FollowersFollow
0SubscribersSubscribe